Open access
Open access
Powered by Google Translator Translator

Archives

WHO: Herd immunity, lockdowns and COVID-19

18 Oct, 2020 | 23:19h | UTC

Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19 – World Health Organization

 

Commentary on Twitter

 


New studies show reduced prevalence and severity of SARS-CoV-2 infection in ABO blood group O

18 Oct, 2020 | 23:16h | UTC

Study 1: Reduced prevalence of SARS-CoV-2 infection in ABO blood group O – Blood Advances

Study 2: The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 – Blood Advances

Commentaries: People with blood type O may have lower risk of Covid-19 infection and severe illness, two new studies suggest – CNN AND Studies offer new evidence for possible link between blood type and COVID-19 susceptibility – American Society of Hematology

 


Answering key questions about COVID-19 vaccines

18 Oct, 2020 | 23:10h | UTC

Answering Key Questions About COVID-19 Vaccines – JAMA

 

Commentary on Twitter

 


NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid)

18 Oct, 2020 | 23:14h | UTC

A dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) – National Institute for Health Research

News Release: Living with COVID: NIHR publishes dynamic themed review into ‘ongoing COVID’

Commentaries: Coronavirus: ‘Long Covid could be four different syndromes’ – BBC AND Long covid could be four different syndromes, review suggests – The BMJ AND ‘Long COVID’ may affect multiple parts of body and mind, doctors say – Reuters

 


Acute Respiratory Distress Syndrome: Contemporary management and novel approaches during COVID-19

18 Oct, 2020 | 23:11h | UTC

Acute Respiratory Distress Syndrome: Contemporary Management and Novel Approaches during COVID-19 – Anesthesiology

Source: Grupo UTI Clínica HCFMUSP

 

Commentary on Twitter

 


Postlicensure evaluation of COVID-19 Vaccines

18 Oct, 2020 | 23:08h | UTC

Postlicensure Evaluation of COVID-19 Vaccines – JAMA

 


Randomized trial: Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women

18 Oct, 2020 | 23:06h | UTC

Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women: multicentre randomised controlled trial – The BMJ

Commentary: For Urinary Incontinence, No Need to Add Biofeedback to Pelvic Floor Exercises – NEJM Journal Watch

 

Commentary on Twitter

 


Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

18 Oct, 2020 | 23:07h | UTC

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes – The Lancet Respiratory Medicine

 

Commentary on Twitter

 


New PLOS pricing test could signal end of scientists paying to publish free papers

18 Oct, 2020 | 23:02h | UTC

New PLOS pricing test could signal end of scientists paying to publish free papers – Science

 


Randomized trial: Targeting rehabilitation to improve outcomes after total knee arthroplasty in patients at risk of poor outcomes

18 Oct, 2020 | 23:04h | UTC

Targeting rehabilitation to improve outcomes after total knee arthroplasty in patients at risk of poor outcomes: randomised controlled trial – The BMJ

Commentary: Self-Directed Physical Therapy Effective After Total Knee Arthroplasty – NEJM Journal Watch

 

Commentaries on Twitter

 


SCCM International consensus conference on prediction and identification of long-term impairments after critical illness

18 Oct, 2020 | 22:59h | UTC

Society of Critical Care Medicine’s International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness – Critical Care Medicine

Systematic review: Prediction Models for Physical, Cognitive, and Mental Health Impairments After Critical Illness: A Systematic Review and Critical Appraisal – Critical Care Medicine

Source: Grupo UTI Clínica HCFMUSP

 

Commentary on Twitter

https://twitter.com/Michael_Harhay/status/1316728913368952834

 


[Abstract Only] Study: Comparison of amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders

18 Oct, 2020 | 23:00h | UTC

Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial – The Lancet Psychiatry (link to abstract – $ for full-text)

 

Commentary on Twitter

https://twitter.com/TheLancetPsych/status/1317014163823104000

 


Guideline on anesthesia and sedation in breastfeeding women

18 Oct, 2020 | 23:01h | UTC

Guideline on anaesthesia and sedation in breastfeeding women 2020 – Anaesthesia

Commentary: Guidelines Indicate Breastfeeding Is Safe After Maternal Anesthesia – Physician’s Briefing

 

Commentary on Twitter

 


Guideline: Management and prevention of anemia (acute bleeding excluded) in adult critical care patients

18 Oct, 2020 | 22:52h | UTC

Management and prevention of anemia (acute bleeding excluded) in adult critical care patients – Anaesthesia Critical Care & Pain Medicine

 

Commentary on Twitter

 


[Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19

16 Oct, 2020 | 09:42h | UTC

Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results – medRxiv

Commentary: Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments – Science

 

Commentaries on Twitter

 


Scientific consensus on the COVID-19 pandemic: we need to act now

16 Oct, 2020 | 09:41h | UTC

Scientific consensus on the COVID-19 pandemic: we need to act now – The Lancet

Commentary: Herd immunity approaches to COVID-19 control are a ‘dangerous fallacy’, say authors of open letter – The Lancet

 


Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic

16 Oct, 2020 | 09:38h | UTC

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA

Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

 

Commentary on Twitter

https://twitter.com/seymoc/status/1316765788523511809

 


Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign

16 Oct, 2020 | 09:37h | UTC

Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign – Science

 

Commentary on Twitter

 


Researchers worldwide fight to work and teach amid COVID-19

16 Oct, 2020 | 09:35h | UTC

Researchers worldwide fight to work and teach amid COVID-19 – Nature

 


NEW Special issue of The Global Burden of Disease Study 2019

16 Oct, 2020 | 09:31h | UTC

Homepage: Global Burden of Disease Study 2019 – The Lancet

Editorial: Global health: time for radical change? – The Lancet

 

Commentary on Twitter

 


Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19

16 Oct, 2020 | 09:34h | UTC

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review – Cochrane Library

 

Commentary on Twitter

 


Review: Why and how vaccines work

16 Oct, 2020 | 09:32h | UTC

Why and How Vaccines Work – Cell

 

Commentary on Twitter

 


Life expectancy after bariatric surgery in the Swedish Obese Subjects Study

16 Oct, 2020 | 09:29h | UTC

Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study – New England Journal of Medicine

Commentary: Higher average life expectancy after obesity surgery – University of Gothenburg

 

Commentary on Twitter

https://twitter.com/NEJM/status/1316816109279084545

 


[Abstract Only] Randomized trial: Upadacitinib vs. Abatacept in rheumatoid arthritis

16 Oct, 2020 | 09:28h | UTC

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Rheumatoid Arthritis: When DMARDs Fail, Can JAK Inhibitors Step In? – Physician’s Weekly

 


Systematic review: Management of colonic diverticulitis

16 Oct, 2020 | 09:25h | UTC

Management of Colonic Diverticulitis – Agency for Healthcare Research and Quality

Full report: Management of Colonic Diverticulitis

Evidence summary: Management of Colonic Diverticulitis

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.